5 Stocks Insiders are Buying Now

4. Janux Therapeutics, Inc. (NASDAQ:JANX)

Insider Purchase Date: November 13

A lot of insider buying activity has been taking place at Janux Therapeutics, Inc. (NASDAQ:JANX), a California-based biopharma company. Earlier in November Jay Lichter, a director and 10% owner at the company, bought a whopping $4.9 million worth of company shares at $5.87 a piece. Tighe Reardon, Janux Therapeutics, Inc. (NASDAQ:JANX)’s acting CFO, also amassed 849,854 shares of the company at a per-share price of $5.87.